Adding to Life
Why BioGenomics
Quality that matches only the best
BioGenomics establishes biosimilarity by a thorough characterisation process, using modern technologies which are compliant with global regulatory requirements.
All our product are animal-origin free.
cGMP Production Facility
WHO-GMP certified. Advanced formulation capabilities. ISO 9001:2015, ISO 14001 and ISO 45001 certified.
Strong IP portfolio for Value Creation
BioGenomics’ innovations cover super vectors for mammalian and microbial expressions, codon optimised gene sequences, protein folding technologies, novel purification and isolation technologies.
Indigenous to the core
Completely indigenous technology at each stage of development, including cell lines and process development.
All manufacturing processes established for robustness, using modern ‘Quality by Design’ concepts.
International standard clinical safety and efficacy trials
Clinical studies designed with reference to EMA guidelines and conducted to ICH-GCP.
Statistically significant and meaningful clinical trials.
Clinical trials aimed at establishing biosimilarity, immunogenicity and efficacy using globally sourced reference products.